Readiness for Drug Information Service Provision in Community Pharmacies in Akwa-Ibom State, Nigeria
Journal of Advances in Medical and Pharmaceutical Sciences,
This study was aimed at assessing the readiness for drug information service (DIS) provision at community pharmacies in Akwa Ibom state using a cross sectional, observational study approach. A pretested, validated questionnaire was adapted for the study. A total of 187 premises were enlisted for visits with questionnaires targeted at the superintendent pharmacists for desired responses. Response rate was 93.6%. Respondents were male (77, 44%) and female (98, 56%) with mean years of experience of respondents as 18.7 years. All respondents were aware of DIS terminologies and believed the concept to include enquiries on dosing (75%), side effects of drugs (99%), safety of drugs in cases such as pregnancy (79%), drug route of administration (80%), pill identification (66%) and substitutes to requested drugs (78%). Responses to limitations in discharging efficient DIS include non-trending service style (26%), premises requiring restructuring (26%), prohibitive setting up cost (17%) and non-availability of trained personnel (7%). At the time of this study, available resources for DIS in the premises included reference books (90%), periodicals (19%), and internet access through smart phones (60%). Secondary and tertiary sources of drug information were essentially relied on for DIS provision in the study area. There was significant association between socio-demographic characteristics such as age with readiness status (p<0.05). There was poor in-service training for effective DIS provision. Summarily, there was no significant difference (p > 0.05) in the DIS approach across the state. There is need for improvement in facilities and resources for efficient discharge of DIS in the study area.
- Drug information service (DIS)
- pharmaceutical care
- community pharmacies
- limitations to DIS provision
How to Cite
Oparah A, Arigbeosula EM. Evaluation of community pharmacies involvement in primary health care. Tropical Journal of Pharmaceutical Research. 2002;1(2):67-74.
Ogbonna BO, Ejim CE, Ikebudu CL, Uzodinnma S, Orji CE. Pharmaceutical care and community practice in Nigeria. European Journal of Pharmaceutical and Medical Research and Medical Research. 2015;2:33-42.
Wojas AM, Graham AA. Drug information services: the answer to your drug-related questions. American Family Physician. 2009;80(7):670-672.
Makary MA, Daniel M. Medical error-the leading cause of death in the US. British Medical Journal. 2016;353:i2139.
Alamri SA, Al Jaizani RA, Naqvi AA, Al Ghamdi MS. Assessment of drug information service in public and private sector tertiary care hospitals in the Eastern province of Saudi Arabia. Journal of Pharmacy Education and Practice. 2017;5(3):37-42.
Tefera YG, Gebresillasie BM, Ayele AA, Belay YB, Emira YK. The characteristics of drug information inquiries in an Ethiopian University hospital: A two-year observational study. Scientific Reports. 2019;13835.
Thomas D, Zachariah S. Drug informatics to promote pharmacy profession in India. Indian Journal of Medical Informatics. 2010;5(3):1-12.
Taylor J, Berger B, Anderson-Harper H, Grimley D. Pharmacists readiness to assess consumers over-the-counter product selection. Journal of the American Pharmacists Association. 2000;40(4):487.
Kalra M, Pakhale SP, Khatak M, Khatak S. Drug information centres-need of the hour. Internationale Pharmaceutica Sciencia. 2011;1(1):69-79.
Nicholls J, MacKenzie C, Braund R. Preventing drug-related adverse events following hospital discharge: the role of a pharmacist. Integrated Pharmacy Research and Practice. 2017;6:61-69.
Cochran WG. Sampling techniques. John Wiley and Sons 2nd ed; 1977.
Nidal J, Waheed S. Drug information for community pharmacies: Survey on needs of drug information with special focus on new information technology. An-Najah University Journal of Research in Nursing Sciences. 2003;17(2):292.
Rosenberg JM, Koumis t, Nathan JP, Cicero LA, McGuire H. Current status of pharmacist-operated drug information centres in the United States. American Journal of Health System Pharmacists. 2004;61(19):2023-32.
Brunelti L, Hermes-De Santos E. The Internet as a Drug Information Resource. US Pharmacist, 2010; 35(1): Epub.
Hassali MA, Khan TM, Shaife AA. Use of drug information resources by the community pharmacist in Penang, Malaysia. The Journal of Innovations in Health Informatics. 2010;18(30):213-6.
International Pharmaceutical Federation (FIA). Medicines Information Strategic development. The Hague; 2017.
Drug Information: A guide for Pharmacists. New York: McGraw-Hill; 2018.
Alfrasheedy KCB, Ibrahim MI. Do community pharmacists in Nepal have a role in advance drug reaction reporting system. Australian Medical Journal. 2013; 6(2):100-103.
Ahirway CS, Mishra AK, Pathak AK, A need to be fulfilled. Drug Information Service. IOSR Journal of Pharmacy. 2017;6(1):15-19.
Hall V, Gomez C, Fernandez B, Llimos F. Situation of drug information centres in Costa Rica. Pharmacy Practice. 2006; 4(2):83-87.
Adibe MO. Assessment of attitude and behaviour of health professionals towards provision of drug information in Enugu State. International Journal of Drug Development Research. 2010; 2:555-564.
Kelly AB, Kristin AC, Tara R. Documentation of patient care services in a community pharmacy setting. Journal of the American Pharmacists Association. 2006;46(3):378-384.
Lim LY, Chui WK. Pharmacist-operated drug information centres in Singapore. Journal of Clinical Pharmacy and Therapeutics. 1999;24(1):33-42.
Abstract View: 54 times
PDF Download: 19 times